Atlas FDA

ORAQUICK HCV RAPID ANTIBODY TEST

FDA premarket approval P080027/S022 · decided 2016-02-20

Approval details

PMA number
P080027
Supplement
S022
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ORAQUICK HCV RAPID ANTIBODY TEST
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Applicant
OraSure Technologies, Inc.
Date received
2016-02-01
Decision date
2016-02-20
Days to decision
19 days
Decision code
OK30
Product code
MZO
Advisory committee
Microbiology
Expedited review
No
Location
Bethlehem, PA
Statement
Addition of a new supplier for peptides used in the manufacture of the OraQuick® HCV Rapid Antibody Test.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OraQuick Ebola Rapid Antigen Test (DEN190025)OraSure Technologies, Inc.2019-10-10
COMPOUND W FREEZE OFF WART REMOVAL SYSTEM (K060859)OraSure Technologies, Inc.2006-07-18
HISTOFREEZER WART REMOVAL SYSTEM OR OTHER PROPRIETARY NAME (K023487)OraSure Technologies, Inc.2003-03-20
OTI BENZODIAZEPINES INTERCEPT MICRO-PLATE EIA MODEL #1110I (K013882)OraSure Technologies, Inc.2002-04-17
UPLINK TEST SYSTEM (K020371)OraSure Technologies, Inc.2002-04-03
INTERCEPT ORAL FLUID DRUG TEST ORAL SPECIMEN COLLECTION DEVICE, MODEL 503-XXXX (K011057)OraSure Technologies, Inc.2001-06-06
STC CANNABINOIDS INTERCEPT MICRO-PLATE EIA, MODEL 1118I (K002375)OraSure Technologies, Inc.2001-01-26
STC BARBITURATES INTERCEPT MICRO-PLATE EIA, MODEL 1108I (K001976)OraSure Technologies, Inc.2000-12-06